Test Drive Our New Site! We have some improvements in the works that we're excited for you to experience. Click here to try our new, faster, mobile friendly beta site. We will be maintaining our current version of the site thru the end of 2024, so you can switch back as our improvements continue.
Legislation Quick Search
04/19/2024 11:40 AM
Pennsylvania House of Representatives
https://www.legis.state.pa.us/cfdocs/Legis/CSM/showMemoPublic.cfm?chamber=H&SPick=20190&cosponId=30062
Share:
Home / House Co-Sponsorship Memoranda

House Co-Sponsorship Memoranda

Subscribe to PaLegis Notifications
NEW!

Subscribe to receive notifications of new Co-Sponsorship Memos circulated

By Member | By Date | Keyword Search


House of Representatives
Session of 2019 - 2020 Regular Session

MEMORANDUM

Posted: August 8, 2019 09:24 AM
From: Representative Wendy Ullman
To: All House members
Subject: Recognizing September 2019 as Benzodiazepine Addiction Recovery Month
 
Benzodiazepines, commonly known as “benzos,” are a highly addictive class of prescription medications used as sedatives and muscle relaxants, which include well-known brands such as Xanax and Valium. A benzodiazepine addiction can be developed within a few weeks of use. Due to increased usage, it is vital that Pennsylvanians be aware of the signs and symptoms of benzodiazepine addiction. Once addicted, an individual can demonstrate many physical, personal, and psychological symptoms including slurred speech, drowsiness, rage, mania, reclusive behavior, and loss of personal relationships. Unfortunately, there is no quick fix for beating addiction, and treatment can be very lengthy as gradual reduction is the most effective method in ending benzodiazepine dependency.

As stewards of public health and safety, we must encourage every person to learn more about benzodiazepine abuse in order to be informed of its side effects and treatment. As such, I plan to introduce a resolution that will designate the month of September 2019 as “Benzodiazepine Addiction Recovery Month.” Your consideration is greatly appreciated.



Introduced as HR492